Loxo Oncology | search
Click here to view Loxo Oncology news from 60+ newspapers.
Bookmark or Share- Loxo Oncology, Inc. - BioCTLoxo Oncology is a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers. Our pipeline focuses on cancers that are uniquely dependent on single gene abnormalities, such that a single drug has the potential to treat cancer with dramatic effect.
- A Medicine Company | Eli Lilly and CompanyLearn the latest information on the availability of Lilly diabetes and obesity medicines. Learn how to protect yourself from counterfeit Mounjaro ® and Zepbound ® and unapproved tirzepatide products.
- Loxo Oncology at Lilly Announces Updated Data from the Phase 1/2 BRUIN ...Loxo Oncology at Lilly brings together the focus and spirit of a biotech with the scale and resources of large pharma, with the goal of rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating new oncology medicines that unequivocally work early in clinical development and will matter to patients.
- Lilly to buy Loxo Oncology for $8B | BioPharma DiveEli Lilly will buy Loxo Oncology for roughly $8 billion, announcing a cash tender offer Monday that would pay a 68% premium on the start-up's shares and make the Indianapolis-based drugmaker the latest big pharma to strike a significant, cancer-focused deal.
- Lilly cashes in on Loxo buyout with FDA approval for first-in-class ...In two firsts, Eli Lilly has won its first approval for a pipeline drug coming out of the $8 billion acquisition of Loxo Oncology—and it's the first therapy specifically meant for cancer...
More
